Sign up to save your podcasts
Or
Share From Visibility to Revenue: Building a Medtech GTM System
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
From Visibility to Revenue: Building a Medtech GTM System
Many small and mid-sized medtech companies believe that more visibility will solve their growth challenges. More conferences, more content, more campaigns.
But visibility alone does not create predictable revenue.
In this episode of MATCH B2B Insights, we explore why even innovative medical device companies struggle to convert interest into consistent pipeline - and what a real commercial system should look like.
Together with Benny Fluman, Daniel Weiss and Brian Newman, we break down the three buyer journeys that most medtech companies must design:
• Hospitals and IDNs with complex decision committees
• Clinics and physician groups with workflow-driven decisions
• Distributors and channel partners who must prioritize your product
We also discuss how small teams can build revenue infrastructure without the resources of companies like Medtronic or Boston Scientific, and how AI can support a disciplined go-to-market system rather than create noise.
If you lead marketing, sales, or commercial strategy in a 20–50 person medtech company selling into the U.S. or global markets, this episode will give you a practical framework for building a predictable pipeline.
View all episodes
By Benny FlumanMany small and mid-sized medtech companies believe that more visibility will solve their growth challenges. More conferences, more content, more campaigns.
But visibility alone does not create predictable revenue.
In this episode of MATCH B2B Insights, we explore why even innovative medical device companies struggle to convert interest into consistent pipeline - and what a real commercial system should look like.
Together with Benny Fluman, Daniel Weiss and Brian Newman, we break down the three buyer journeys that most medtech companies must design:
• Hospitals and IDNs with complex decision committees
• Clinics and physician groups with workflow-driven decisions
• Distributors and channel partners who must prioritize your product
We also discuss how small teams can build revenue infrastructure without the resources of companies like Medtronic or Boston Scientific, and how AI can support a disciplined go-to-market system rather than create noise.
If you lead marketing, sales, or commercial strategy in a 20–50 person medtech company selling into the U.S. or global markets, this episode will give you a practical framework for building a predictable pipeline.